2023-07-19T00:51:11Z
ENA-FIRST-PUBLIC
2023-07-19T00:51:11Z
ENA-LAST-UPDATE
SAMN31740231
External Id
GSM6732467
External Id
2023-07-19T00:51:11Z
INSDC first public
2023-07-19T00:51:11Z
INSDC last update
public
INSDC status
SRS15765582
SRA accession
GSM6732467
Submitter Id
NCBI
broker name
Expanded TIL
cell line
CD8+
cell type
missing
collection_date
human
common name
female
gender
missing
geo_loc_name
1%
infusion percent_cd4
99%
infusion percent_cd8
8.09E+10
number til_infused
Homo sapiens
organism
87
overall survival_months
0
pfs censor_at_12_months
87
pfs months
CR
response
Homo sapiens
scientific_name
TIL ACT Product
source_name
0
survival censor
TIL ACT Product
tissue
Patient 14 CD8+ [Pt14_CD8 RNA-seq]
title
TIL ACT
treatment
16992
trial